Publications by authors named "Marco Talarico"

Claim this Profile
F
Fifteen years of use of functional imaging in multiple myeloma: where we started and where we are going.
Elena Zamagni, Marco Talarico

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Uncommon co-occurrence of different renal histopathological entities in a patient with multiple myeloma and lymphoplasmacytic lymphoma.
Marco Talarico, Gisella Vischini, Simona Barbato, Roberta Restuccia, Simone Masci

Front Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home.
Flavia Bigi, Mauro Fiacchini, Roberta Restuccia, Simone Masci, Gaia Mazzocchetti, Marco Talarico

Clin Exp Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-Cell Redirecting Therapies in Multiple Myeloma: Pathogenesis and Management of Toxicities Beyond CRS and ICANS.
Katia Mancuso, Marco Talarico, Enrica Manzato, Simona Barbato, Paola Tacchetti

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idecabtagene vicleucel (ide-cel) for the treatment of triple-class exposed relapsed and refractory multiple myeloma.
Katia Mancuso, Simona Barbato, Marco Talarico, Paola Tacchetti, Elena Zamagni

Expert Opin Biol Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients-A Systematic Review.
Flavia Bigi, Enrica Manzato, Simona Barbato, Marco Talarico, Michele Puppi

Pharmaceuticals (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-drug conjugates, bispecific antibodies and CAR-T cells therapy in multiple myeloma.
Paola Tacchetti, Marco Talarico, Simona Barbato, Lucia Pantani, Katia Mancuso

Expert Rev Anticancer Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between Malocclusion and Mandibular Fractures: An Experimental Study Comparing Dynamic Finite Element Models and Clinical Case Studies.
Giorgio Novelli, Andrea Filippi, Andrea Cartocci, Sergio Mirabella, Marco Talarico

Bioengineering (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma.
Katia Mancuso, Elena Zamagni, Vincenza Solli, Liliana Gabrielli, Marta Leone, Marco Talarico

Front Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma.
Francesca Bonello, Serena Rocchi, Gregorio Barilà, Michela Sandrone, Marco Talarico

Front Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis